sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Implementation of Coordinated Spontaneous Awakening and Breathing Trials Using Telehealth-Enabled, Real-Time Audit and Feedback for Clinician AdHerence: A Type II Hybrid Effectiveness-Implementation

$1,029,882

Colin Kerst Grissom · Ihc Health Services, Inc. · U01 · FY2022 · HL

SBIR: IND-enabling development of IN-007, an inhaled muco-trapping immunotherapy for COVID19 and other ACE2-targeted infections

$1,024,986

Jeff T Hutchins · Inhalon Biopharma, Inc. · R44 · FY2024 · AI

IND-enabling development for IN-003, an inhaled mAb therapy against human metapneumovirus infection

$1,024,942

Jeff T Hutchins · Inhalon Biopharma, Inc. · R44 · FY2024 · AI

DNA Replication, Cancer and Chemotherapy

$1,024,926

Melvin Depamphilis · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD

IND-enabling development for IN-003, an inhaled mAb therapy against human metapneumovirus infection

$1,024,879

Jeff T Hutchins · Inhalon Biopharma, Inc. · R44 · FY2025 · AI

Project 1 - Coronavirus

$1,024,373

Mark R Denison · University Of Alabama At Birmingham · U19 · FY2020 · AI

SBIR: IND-enabling development of IN-007, an inhaled muco-trapping immunotherapy for COVID19 and other ACE2-targeted infections

$1,023,875

Jeff T Hutchins · Inhalon Biopharma, Inc. · R44 · FY2025 · AI

CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences

$1,023,111

Louise Chang Laurent · University Of California, San Diego · U01 · FY2023 · MD

Systems Biology Approaches to Viral Pathogenesis and Immunity

$1,023,092

Michael G Katze · Oregon Health & Science University · U54 · FY2010 · AI

Monoclonal Antibody to Combat Pseudomonas Aeruginosa

$1,021,806

Joanna B. Goldberg · Emory University · R01 · FY2023 · AI

Bioinformatics Framework for Wastewater-based Surveillance of Infectious Diseases

$1,020,879

Matthew Scotch · Arizona State University-Tempe Campus · U01 · FY2022 · LM

Puerto Rico Community Action Research and Engagement (PR-CARE) to Eliminate Disparities in Diagnostic of COVID-19 among Rural Underserved and Vulnerable Populations.

$1,020,748

Marizaida Sanchez · University Of Puerto Rico Med Sciences · U01 · FY2023 · MD

Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies

$1,020,000

Frederick R Blattner · Dnastar, Inc. · R44 · FY2024 · AI

Inhibitors of Coronavirus Fidelity and Cap Methylation as Broadly Applicable

$1,019,771

Mark R Denison · University Of Alabama At Birmingham · U19 · FY2017 · AI

RNAi Screening in Hematopoietic Cells

$1,019,714

Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Leadership, Planning and Evaluation

$1,019,114

Caryn Lerman · University Of Southern California · P30 · FY2022 · CA

A Web Service for Fragment-based Selectivity Analysis of Drug Leads

$1,016,453

John Laurence Kulp III · Conifer Point Pharmaceuticals, Llc · R44 · FY2022 · GM

Identifying COVID-19 vaccine deserts using Machine Learning and Geospatial Analyses to target Community -engaged testing for vulnerable rural populations to prevent localized outbreaks

$1,015,320

Brian Hendricks · West Virginia University · U01 · FY2022 · MD

Implementation of Coordinated Spontaneous Awakening and Breathing Trials Using Telehealth-Enabled, Real-Time Audit and Feedback for Clinician AdHerence: A Type II Hybrid Effectiveness-Implementation

$1,014,255

Colin Kerst Grissom · Ihc Health Services, Inc. · U01 · FY2023 · HL

Center for Suicide Research and Prevention - Methods Core

$1,014,253

Andrea Sarah Foulkes · Massachusetts General Hospital · P50 · FY2024 · MH

SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical Use

$1,014,171

Jacek Skarbinski · Kaiser Foundation Research Institute · U01 · FY2023 · CA

Implementation of Coordinated Spontaneous Awakening and Breathing Trials Using Telehealth-Enabled, Real-Time Audit and Feedback for Clinician AdHerence: A Type II Hybrid Effectiveness-Implementation

B-CELL EPITOPE DISCOVERY AND MECHANISMS OF ANTIBODY PROTECTION

CEIRS - SARS-CoV-2 RESEARCH

A Handheld Microchip for GC analysis of breath to screen for COVID-19

COVID-19 Instrumentation in the RTB

SBIR: IND-enabling development of IN-007, an inhaled muco-trapping immunotherapy for COVID19 and other ACE2-targeted infections

IND-enabling development for IN-003, an inhaled mAb therapy against human metapneumovirus infection

DNA Replication, Cancer and Chemotherapy

IND-enabling development for IN-003, an inhaled mAb therapy against human metapneumovirus infection

Project 1 - Coronavirus

SBIR: IND-enabling development of IN-007, an inhaled muco-trapping immunotherapy for COVID19 and other ACE2-targeted infections

CO-CREATE-Ex: Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences

Systems Biology Approaches to Viral Pathogenesis and Immunity

Monoclonal Antibody to Combat Pseudomonas Aeruginosa

Bioinformatics Framework for Wastewater-based Surveillance of Infectious Diseases

Puerto Rico Community Action Research and Engagement (PR-CARE) to Eliminate Disparities in Diagnostic of COVID-19 among Rural Underserved and Vulnerable Populations.

Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies

Inhibitors of Coronavirus Fidelity and Cap Methylation as Broadly Applicable

RNAi Screening in Hematopoietic Cells

Leadership, Planning and Evaluation

A Web Service for Fragment-based Selectivity Analysis of Drug Leads

Identifying COVID-19 vaccine deserts using Machine Learning and Geospatial Analyses to target Community -engaged testing for vulnerable rural populations to prevent localized outbreaks

Implementation of Coordinated Spontaneous Awakening and Breathing Trials Using Telehealth-Enabled, Real-Time Audit and Feedback for Clinician AdHerence: A Type II Hybrid Effectiveness-Implementation

Center for Suicide Research and Prevention - Methods Core

SARS-CoV-2 Serological Antibody Testing for Disease Surveillance and Clinical Use